Wednesday, 28 September 2016
Hemispherx BioPharma Inc.
|AMEX : HEB|
26 Sep 16 00:00
03:22 | 24/9/16
Curious Investors have been seeking information about shares of Hemispherx Biopharma, Inc. (:HEB) after the stock moved 2.29%, hitting the $1.34 price point following a recent trade. more»
03:19 | 23/9/16
Reaching the $1.36 price, stocks of Hemispherx Biopharma, Inc. (:HEB) have garnered a closer look from investors due to the price moving 1.99% following a recent trading session. more»
00:33 | 23/9/16
Hemispherx BioPharma, Inc (NYSEMKT:HEB) announced that the Court of Chancery of the State of Delaware has issued an order granting final approval of a settlement of the derivative and class action case captioned Kastis, et al. more»
00:22 | 20/9/16
19, 2016 -- Hemispherx Biopharma (NYSE MKT:HEB) (the “Company”), announced today that, based on a notice received on September 15, 2016 from the New York Stock Exchange, Inc., the Company has regained compliance with the NYSE MKT's ... more»
09:34 | 7/9/16
MarketResearchStore149 The Market research comprehensive data on Hemispherx Biopharma, Inc Market Product Pipeline Review, 2016, is well organized and easily readable. more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW